Gate App Options Now Live! Test and Win Big
📅 Event Period: September 30, 2025 – October 17, 2025
- Submit valid feedback to receive 10–100 USDT.
- Complete at least 10,000 USDT in cumulative options trading volume to participate.
👉 Register now :https://www.gate.com/campaigns/2063
Details: https://www.gate.com/zh-tw/announcements/article/47455
Leap Therapeutics completed a $58.88 million cash private sale led by Winklevoss Capital.
[Leap Therapeutics completes $58.88 million cash private sale led by Winklevoss Capital] Biotechnology company Leap Therapeutics (NASDAQ: LPTX) today announced that it has completed the previously announced private sale led by Winklevoss Capital, raising $58,888,888 in cash to initiate its digital asset financial strategy. Winklevoss Capital will provide funding and strategic support to help Leap build and execute its digital asset financial strategy. According to the lead investor agreement, the Leap board of directors will increase to 12 members, and Winklevoss Capital will have the right to nominate two individuals to the Leap board, one of whom will also serve as the chairperson of the board. Morgan, Lewis & Bockius LLP serves as Leap's legal advisor, while Cooley LLP serves as Winklevoss Capital's legal advisor.